GleamWall
中文EN

BON Bon Natural Life Ltd Annual reports only

Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 1816815 · Fiscal year ends 09/30

Financial factors as of 2025-09-30 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-21.7%
TTM net income YoY-601.0%
TTM EPS YoY-117.4%
Revenue 3-yr CAGR-14.5%
Net income 3-yr CAGR—

Margins

Gross margin20.8%
Operating margin-8.7%
Net margin-10.7%
FCF margin0.7%
EBITDA margin-2.9%

Returns

ROE-3.9%
ROA-2.7%
ROIC (approx.)-2.6%
Asset turnover0.25x

Leverage & solvency

Liabilities / assets31.9%
Debt / equity0.03x
Current ratio1.74x
Interest coverage-4.43x

Cash quality & payout

Operating cash flow / net income-0.07x
Accruals ratio-2.9%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-09-30FY20242024-09-30
Income statement
Revenue$18.67M$23.84M
Cost of revenue$14.79M$16.73M
Gross profit$3.88M$7.11M
R&D expense$754,193$1.62M
SG&A expense$4.31M$3.35M
Operating income-$1.62M$1.87M
Interest expense$366,180$303,325
Pretax income-$1.71M$715,939
Income tax$339,414$351,179
Net income-$1.99M$398,172
EBITDA-$535,580$2.98M
EPS (basic)-0.724.17
EPS (diluted)-0.724.14
Weighted avg. shares (diluted)2.76M96,114
Balance sheet
Cash & equivalents$6.27M$658,610
Receivables$11.01M$11.78M
Inventory$3.31M$1.57M
Current assets$45.76M$39.79M
PP&E, net$18.16M$15.01M
Intangibles$6.42M$776,995
Total assets$85.19M$61.77M
Current liabilities$26.31M$16.45M
Short-term debt$1.08M$461,765
Long-term debt$842,815$970,061
Total debt$1.92M$1.43M
Total liabilities$27.19M$17.42M
Shareholders' equity$57.55M$43.91M
Net debt-$4.34M$773,216
Shares outstanding—3.97M
Cash flow statement
Operating cash flow$141,115-$7.72M
Capital expenditure$6,827$7,047
Free cash flow$134,288-$7.73M
Investing cash flow-$10.00M-$15,727
Financing cash flow$15.45M$8.76M
Depreciation & amortization$1.09M$1.11M
Stock-based compensation$1.39M$1.32M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.